Therapeutics , Targets , and Chemical Biology Hepatocarcinogenesis Driven by GSNOR De fi ciency Is Prevented by iNOS Inhibition

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver.

  2013cited by this paper
• Regulation of DNA repair by S-nitrosylation.

  2012cited by this paper
• Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine

  2011cited by this paper
• Lymphocyte Development Requires S-nitrosoglutathione Reductase

  2010cited by this paper
• S-Nitrosylation from GSNOR Deficiency Impairs DNA Repair and Promotes Hepatocarcinogenesis

  2010cited by this paper
• Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

  2009cited by this paper
• Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.

  2008cited by this paper
• Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats.

  2008influential reference
• Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

  2008cited by this paper
• Expression of inducible nitric oxide (NO) synthase but not prevention by its gene ablation of hepatocarcinogenesis with fibrosis caused by a choline-deficient, L-amino acid-defined diet in rats and mice.

  2007cited by this paper
• Hepatocellular carcinoma pathogenesis: from genes to environment

  2006cited by this paper
• IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

  2005cited by this paper
• Protein S-nitrosylation: purview and parameters

  2005cited by this paper
• CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life

  2005cited by this paper
• Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

  2005cited by this paper
• Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock.

  2004cited by this paper
• Multiple chromosomal abnormalities in human liver (pre)neoplasia.

  2004cited by this paper
• NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

  2004cited by this paper
• Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.

  2002influential reference
• Distribution of nitric oxide synthase in normal and cirrhotic human liver

  2002cited by this paper
• Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide.

  2002cited by this paper
• Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.

  2001cited by this paper
• A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans

  2001cited by this paper
• Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma.

  2001cited by this paper
• Repair of O(6)-alkylguanine by alkyltransferases.

  2000influential reference
• Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma

  2000cited by this paper
• Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

  2000cited by this paper
• Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine.

  1999cited by this paper
• NO: an inhibitor of cell death

  1999cited by this paper
• Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.

  1999cited by this paper
• S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme.

  1998cited by this paper
• Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.

  1998cited by this paper
• DNA adducts, mutant frequencies and mutation spectra in lambda lacZ transgenic mice treated with N-nitrosodimethylamine.

  1998cited by this paper
• Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis.

  1997cited by this paper
• 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo*

  1997cited by this paper
• Comprehensive allelotyping of human hepatocellular carcinoma

  1997cited by this paper
• Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine.

  1997cited by this paper
• High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.

  1997cited by this paper
• High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase.

  1997cited by this paper
• O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis.

  1993cited by this paper
• Assay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis(2-nitrobenzoic acid).

  1988cited by this paper
• Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.

  1980cited by this paper

• No citing papers are available for this paper.